Antagonist [ortf]
Paroxysmal atrial fibrillation [dsyn]
Trial [resa]
Background [cnce]
Antiarrhythmic Drugs [phsu]
Safety [hcpp]
effects [qlco]
Receptor, Angiotensin II [aapp, rcpt]
Blockade [ftcn]
Patients [podg]
Structural [spco]
Heart disease [dsyn]
Well [qlco]
Established [qlco]
Clinical [qlco]
Efficacy [qlco]
PREVENT [phsu]
Atrial Fibrillation [patf]
Only [qnco]
Show [inpr]
Patients [podg]
Structural [spco]
Heart disease [dsyn]
Report [inpr]
Primary [qlco]
Outcome [ftcn]
Of [spco]
Antagonist [ortf]
Paroxysmal atrial fibrillation [dsyn]
Trial [resa]
investigated [ftcn]
Effect [qlco]
Olmesartan medoxomil [orch, phsu]
Compared [acty]
placebo [topp]
Atrial Fibrillation [patf]
Burden [idcn]
Patients [podg]
Paroxysmal atrial fibrillation [dsyn]
Structural [spco]
Heart disease [dsyn]
Methods [inpr]
Result [ftcn]
Antagonist [ortf]
Paroxysmal atrial fibrillation [dsyn]
Trial [resa]
prospective [resa]
randomized [resa]
placebo-controlled [resa]
Trial, Multicenter [resa]
Atrial Fibrillation [patf]
Burden [idcn]
Percentage [qnco]
days [tmco]
Documented [hlca]
Episodes [tmco]
Paroxysmal atrial fibrillation [dsyn]
month [tmco]
Follow-up [fndg]
Primary Endpoint [irda]
Study [mnob]
Four [qnco]
Patients [podg]
Documented [hlca]
Paroxysmal atrial fibrillation [dsyn]
Structural [spco]
Heart disease [dsyn]
randomized [resa]
placebo [topp]
mg% [qnco]
olmesartan [orch, phsu]
Concomitant Therapy [topp]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Antiarrhythmic Drugs [phsu]
prohibited [carb, imft, phsu]
Patients [podg]
Using [ftcn]
Daily [tmco]
ECG NOS [diap]
symptoms [ftcn]
Intention [menp]
TREAT [ftcn]
Population [qnco]
Trial [resa]
Patients [podg]
placebo [topp]
Group [idcn]
N NOS [aapp, imft]
olmesartan [orch, phsu]
Group [idcn]
N NOS [aapp, imft]
TELE [gngm]
ecgs [fndg]
Analyzed [resa]
Patients [podg]
Follow-up [fndg]
placebo [topp]
Group [idcn]
ecgs [fndg]
olmesartan [orch, phsu]
Group [idcn]
ecgs [fndg]
Mean [qnco]
TELE [gngm]
ecgs [fndg]
Record [inpr]
Primary Endpoint [irda]
Atrial Fibrillation [patf]
Burden [idcn]
Not [ftcn]
Different [qlco]
Group [idcn]
P NOS [aapp, imft]
secondary [neop]
Outcome [ftcn]
Parameters [fndg]
Including [ftcn]
Quality [qlco]
Life [idcn]
Not [ftcn]
Different [qlco]
Time [tmco]
First [qnco]
atrial fibrillation recurrent [dsyn]
Time [tmco]
Persistent atrial fibrillation [patf]
Hospitalizations [hlca]
Not [ftcn]
Different [qlco]
Group [idcn]
Time [tmco]
Prescription [hlca]
Recovery [acty]
Medication [phsu]
Amiodarone [orch, phsu]
Only [qnco]
Parameter [spco]
Show [inpr]
Early [tmco]
Prescription [hlca]
Amiodarone [orch, phsu]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
Conclusions [idcn]
One [qnco]
Receptor, Angiotensin II [aapp, rcpt]
Blockade [ftcn]
therapy [ftcn]
Not [ftcn]
Atrial Fibrillation [patf]
Episodes [tmco]
Patients [podg]
Documented [hlca]
Paroxysmal atrial fibrillation [dsyn]
Structural [spco]
Heart disease [dsyn]
Clinical Trial [resa]
Registration [hlca]
URL [inpr]
HTTP [idcn]
WWW [mnob]
GOV [gngm]
Unique Identifier [inpr]
Circ [qnco]
